Program Year 2024
General Payments984,011 providers 1,699 companies
Dataset totals — PY2024
$2,647,900,618.22
- Category: General Payments
- Program year: 2024
- Records: 15,350,656
- Providers: 984,011
- Reporting companies: 1,699
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- Dataset-level totals for the labeled program year, General Payments only. Research and Ownership/Investment are separate datasets and are never combined into these figures.
- Methodology & Data — sourcing, labeling, and limitations.
Coverage: program years 2018–2024 are loaded, General Payments only. This page reflects the CMS publication snapshot for PY2024.
Reported totals by company — PY2024 (20 shown)
Sorted by reported total — a dataset fact, not a ranking of conduct.
| Company | Reported | Records | Providers |
|---|---|---|---|
| ABBVIE INC. | $151,450,487.36 | 1,720,108 | 226,590 |
| Stryker Corporation | $119,591,548.14 | 160,304 | 32,182 |
| Medtronic, Inc. | $114,029,328.63 | 341,735 | 77,336 |
| Arthrex, Inc. | $103,853,500.79 | 49,419 | 4,781 |
| Edge Endo LLC | $91,139,126.87 | 11 | 9 |
| Zimmer Biomet Holdings, Inc. | $82,470,882.07 | 32,574 | 7,771 |
| INTUITIVE SURGICAL, INC. | $59,859,550.14 | 115,646 | 16,235 |
| Acerta Pharma LLC | $56,478,483.86 | 609,182 | 137,218 |
| DePuy Synthes Products LLC | $50,211,031.52 | 2,541 | 357 |
| BOSTON SCIENTIFIC CORPORATION | $49,155,631.29 | 265,007 | 69,661 |
| Smith & Nephew, Inc. | $43,694,474.44 | 70,840 | 23,737 |
| Lilly USA, LLC | $40,719,834.97 | 534,681 | 121,219 |
| Amgen Inc. | $40,286,834.88 | 473,035 | 118,346 |
| GENZYME CORPORATION | $37,116,941.76 | 181,497 | 48,471 |
| PFIZER INC. | $37,007,012.35 | 567,787 | 149,207 |
| Abbott Laboratories | $34,137,727.11 | 291,344 | 74,303 |
| Janssen Biotech, Inc. | $29,671,795.95 | 295,232 | 49,734 |
| E.R. Squibb & Sons, L.L.C. | $28,672,085.52 | 234,563 | 63,514 |
| Henry Schein, Inc. | $27,398,345.45 | 2,626 | 1,934 |
| Globus Medical, Inc. | $26,166,124.47 | 23,059 | 4,503 |
Reported totals by specialty — PY2024 (20 shown)
Sorted by reported total.
Other program years
Natures of payment
- Royalty or License
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
- Consulting Fee
- Food and Beverage
- Acquisitions
- Travel and Lodging
- Education
- Honoraria
- Current or prospective ownership or investment interest
- Grant
- Compensation for serving as faculty or as a speaker for a medical education program
- Gift
- Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program
- Debt forgiveness
- Long term medical supply or device loan
- Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program
- Charitable Contribution
- Entertainment